Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Marine Pollution Bulletin|January 24, 2024
Microplastic ingestion in aquatic and soil biota: A comprehensive review of laboratory studies on edible size and intake patternDokyung Kim, Sang A Kim, Sun-Hwa Nam, et al.
Histopathology|May 7, 2026
Clinicopathological spectrum of CD10, BCL6, MUM1 triple-positive diffuse large B-cell lymphoma and large B-cell lymphoma with IRF4 rearrangementSei Na, Ki Rim Lee, Yoon Kyung Jeon, et al.
Molecular Diagnosis & Therapy|April 3, 2024
Diagnostic Approaches to Investigate JAK2-Unmutated Erythrocytosis Based on a Single Tertiary Center ExperienceYoungeun Lee, Soo Hyun Seo, Jinho Kim, et al.
Annals of Hematology|July 31, 2021
Evaluation of the need for cytoreduction and its potential carcinogenicity in children and young adults with myeloproliferative neoplasmsHyoung Soo Choi, Junshik Hong, Sang Mee Hwang, et al.
Thrombosis Research|October 7, 2023
Increased risk of venous and arterial thromboembolism in patients with colorectal cancer receiving cetuximab-based combination chemotherapy: A population-based study in KoreaHo-Young Yhim, Juhyun Lee, Kyoung Ha Kim, et al.
Thrombosis and Haemostasis|June 28, 2022
Treatment and Bleeding Complications of Cancer-Associated Venous Thromboembolism: A Korean Population-Based StudySang-A Kim, Ju Hyun Lee, Ji Yun Lee, et al.
Molecular Medicine Reports|June 1, 2017
Araliasaponin II isolated from leaves of Acanthopanax henryi (Oliv.) Harms inhibits inflammation by modulating the expression of inflammatory markers in murine macrophagesYun-Soo Seo, Seok-Jeon Lee, Zhi Li, et al.
Annals of Hematology|November 21, 2018
Utility of allogeneic hematopoietic stem cell transplantation using international donors in a homogenous ethnic population: question in the era of various alternative donorsSang-A Kim, Jayoun Lee, Joon Ho Moon, et al.
The Oncologist|July 23, 2025
ALK-positive adult histiocytosis with a TFG-ALKfusion geneJi Yun Lee, Ki Rim Lee, Sei Na, et al.
Leukemia & Lymphoma|October 22, 2024
MG4101, an allogeneic natural killer cell, in patients with relapsed or refractory acute myeloid leukemia: a pilot studySang-A Kim, Miyoung Jung, Hyojin Kim, et al.
Pageof 7